Results 111 to 119 of about 42,247 (119)

A characterization of anxiolytic-like actions induced by the novel NMDA/glycine site antagonist, L-701,324

Psychopharmacology, 1998
Jolanta H Kotlińska
exaly  

Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma

Cancer Chemotherapy and Pharmacology, 2011
Jane E Minturn, Garrett M Brodeur, John M Maris   +2 more
exaly  

Endothelin ETB receptor antagonist, RES-701-1: effects on isolated blood vessels and small intestine

European Journal of Pharmacology, 1994
Hideaki Karaki, Sri Agus Sudjarwo, Masatoshi Hori   +2 more
exaly  

A phase I trial of CEP-701 + gemcitabine in patients with advanced adenocarcinoma of the pancreas

Investigational New Drugs, 2008
Daniel Mulkerin, Jordan Berlin, Lockhart A Craig   +2 more
exaly  

Differential effects of glycine on the anticonvulsant activity of D-cycloserine and L-701,324 in mice

Pharmacological Reports, 2011
Wlaź Piotr, Poleszak Ewa, Piotr Wlaź   +2 more
exaly  

The NMDA/glycine receptor antagonist, L-701,324, produces discriminative stimuli similar to those of ethanol

European Journal of Pharmacology, 1997
Jolanta H Kotlińska, Sture Liljequist
exaly  

The direct effect of the international standard on auditing – 701 requirements on audit profession concerning the reimbursement costs: case study of Jordanian finance industry

Asian Journal of Accounting Research
Esraa Esam Alharasis
exaly  

Green synthesis of (S)‐1‐(furan‐2‐yl)propan‐1‐ol from asymmetric bioreduction of 1‐(furan‐2‐yl)propan‐1‐one using whole‐cell of Lactobacillus paracasei BD101

Chirality
Engin Şahin
exaly  

The exploration of active components of 701 Dieda Zhentong patch and analgesic properties on chronic constriction injury rats

Purinergic Signalling
Anqi Luo, Hong Nie, Nie Hong
exaly